Active Filters

ASH 2023: S1318 benefit for older patients with Ph+ ALL
Dec 9, 2023
Long-term results show combination treatment that skips chemotherapy is effective for older patients with Ph+ ALL
Lung-MAP: A lung cancer precision medicine trial
Dec 1, 2023
Ten years on, Lung-MAP success demonstrates potential of public-private partnerships in clinical research
Clinical Cancer Research journal masthead
Nov 15, 2023
RNA-based molecular subtypes modestly improved predictions for pathologic downstaging in muscle-invasive bladder cancer.
S1316 results on treating malignant bowel obstruction
Aug 1, 2023
Results of large pragmatic trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer
S1826 at ASCO 2023 Plenary Session
Jun 4, 2023
Nivolumab added to AVD chemotherapy expected to become new standard for initial treatment for advanced stage disease in adolescents and adults, based on trial data to be presented at 2023 ASCO Annual Meeting plenary session